What is CATX's dilution risk score?

CATX currently has a DilutionScore of 31/100, indicating medium dilution risk. DilutionWatch monitors CATX SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for CATX?

DilutionWatch tracks 25 SEC filing types for CATX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CATX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CATX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CATX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CATX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CATX Dilution Risk Score: 31/100 (MEDIUM)

📊 Score Breakdown

📋 Offering Ability

50

💰 Cash Runway

0

📊 Float Risk

25

⚠️ Warrant Exposure

40

🔄Convertible Debt—

🌦️ Dilution Forecast

☀️

Clear

No significant dilution signals

9%

💰 Capital Raise 18%

• Active ATM program with $500M remaining capacity

🔔 Track CATX — Get forecast alerts →

💹 Market Data

Market Cap$449.34M

Shares Outstanding114.05M

Float74.34M

Cash$270.93M

Debt$1.61M

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 161.9% shares (2026Q1 vs prior)

137 institutional holders · 98.36M shares

#1 Avidity Partners Management LP 12.10M shares

#2 MORGAN STANLEY 10.22M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 8.76M shares

+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest22.72M

Days to Cover7.3

% of Float30.6%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025

xbrl XBRL CONVERTIBLE Jun 30, 2018

4 INSIDER TRANSACTION Mar 04, 2026

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for CATX Shareholders

Perspective Therapeutics, Inc. (CATX) has a DilutionScore of 31/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

CATX has an active ATM (at-the-market) program with $500.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event.

DilutionWatch tracks over 25 SEC filing types for CATX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CATX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work →